Cargando…
Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
Invariant natural killer T (iNKT) cells recognize CD1d/glycolipid complexes and upon activation with synthetic agonists display immunostimulatory properties. We have previously described that the non‐glycosidic CD1d‐binding lipid, threitolceramide (ThrCer) activates murine and human iNKT cells. Here...
Autores principales: | Jukes, John‐Paul, Gileadi, Uzi, Ghadbane, Hemza, Yu, Ting‐Fong, Shepherd, Dawn, Cox, Liam R., Besra, Gurdyal S., Cerundolo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913735/ https://www.ncbi.nlm.nih.gov/pubmed/26873393 http://dx.doi.org/10.1002/eji.201546114 |
Ejemplares similares
-
Amide Analogues of CD1d
Agonists Modulate iNKT-Cell-Mediated Cytokine Production
por: Wojno, Justyna, et al.
Publicado: (2012) -
Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues
por: Jervis, Peter J., et al.
Publicado: (2012) -
Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
por: Veerapen, Natacha, et al.
Publicado: (2011) -
Design,
Synthesis, and Functional Activity of Labeled
CD1d Glycolipid Agonists
por: Jervis, Peter J., et al.
Publicado: (2013) -
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region
por: Wooldridge, Linda, et al.
Publicado: (2007)